The Department of Urologic Surgery’s Clinical Trials Office has been actively involved in a number of national and university-based trials that allow our patients access to cutting-edge medications, techniques, and diagnostic modalities. Clinical trials are available for many different disease processes. Our experienced staff can quickly determine by phone whether or not you may qualify for a certain trial.
Listed below are several of the current trials that are open for enrollment. If you are interested in finding out whether or not you qualify for participation in one of these trials, please contact Brenda Hughes, RN, CCRC at (615) 343-0445 or email@example.com.
STRIVE: A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide vs. Bicalutamide in Men with Prostate Cancer who have Failed Primary Androgen Deprivation Therapy. MDV3100-09
A Pilot Study to Assess the Technical Feasibility of Robotic Assisted Laparoscopic Interpositioning of the AVANCETM Nerve Graft for Reconstruction of the Neurovascular Bundle, with a Twenty-four Month Follow-up Term to Assess Efficacy
Bladder Cancer and Related Protocols
A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma. Protocol No. N10-1
BOTOX® for the Treatment of Urinary Incontinence due to Neurogenic Detrusor Overactivity in Patients with Multiple Sclerosis. Protocol No. 191622-117
No protocols open now for this indication
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with A Neurological Condition in Pediatric Subjects. Protocol No. OG09002